Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR - ICR / Cancer Research Society Partnership - Research Grants

University of Toronto

$62,500.00

Beyond Cardiotoxicity: Characterizing the Short and Long-term Cardiovascular Side Effects of Breast Cancer Endocrine Treatment

EF 2022-23

Résumé
In the last 15 years, ~300,000 Canadian women have survived breast cancer (BC) thanksto improvementsin BC treatment. However, BC treatments can also be harmful for the heart and vessels, leaving BC survivors at an increased risk of dying from heart, stroke and Alzheimer’s diseases. One BC treatment called aromatase inhibitors appear to increase the risk of cardiovascular mortality by 50%. Despite this, very few studies have looked at the direct effects of aromatase inhibitors on the heart, vessels, and other early risk factorsfor cardiovascular disease. Thisstudy will be the first to examine the short- and long-term impact of aromatase inhibitors on a suite of health indicesrelated to heart, vessel, and brain health in BC survivors.
Programme
CIHR - ICR / Cancer Research Society Partnership - Research Grants
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
488204
Name
Kirkham Amy A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Cancer Research Society Inc.; Cancer Research Society Inc.
Instname2
Cancer Research
Prcname2
Special Cases
Projecttitle
Beyond Cardiotoxicity: Characterizing the Short and Long-term Cardiovascular Side Effects of Breast Cancer Endocrine Treatment
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$62,500
Cihrequipment2
$0
Programname2
CIHR - ICR / Cancer Research Society Partnership - Research Grants
Keyworddelim
Decreasing Secondary Effects Of Treatment; Targets And Biomarkers
Abstract
In the last 15 years, ~300,000 Canadian women have survived breast cancer (BC) thanksto improvementsin BC treatment. However, BC treatments can also be harmful for the heart and vessels, leaving BC survivors at an increased risk of dying from heart, stroke and Alzheimer’s diseases. One BC treatment called aromatase inhibitors appear to increase the risk of cardiovascular mortality by 50%. Despite this, very few studies have looked at the direct effects of aromatase inhibitors on the heart, vessels, and other early risk factorsfor cardiovascular disease. Thisstudy will be the first to examine the short- and long-term impact of aromatase inhibitors on a suite of health indicesrelated to heart, vessel, and brain health in BC survivors.
Competitiondate
202302
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kirkham, Amy A
Approvedterm
1 an 0 mois
Cihrcontribution2
ICR~ $62,500~ $0~